Drug
isatuximab-irfc
Marketed as SARCLISA ESCENA.
Generic name
isatuximab-irfc
Brand names
SARCLISA ESCENA
First FDA approval
2026-07-09
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761445 | SARCLISA ESCENA | 2026-07-09 | SANOFI-AVENTIS U.S. LLC |
Manufacturers
SANOFI-AVENTIS U.S. LLC
Frequently asked questions
When was isatuximab-irfc FDA approved?
Earliest FDA approval on record: 2026-07-09.
What brand names are sold as isatuximab-irfc?
SARCLISA ESCENA.
Sources
Appeal a isatuximab-irfc denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com